Motivational Interviewing to Prevent Suicide in High Risk Veterans

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Department of Veterans Affairs
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT01544127
First received: February 28, 2012
Last updated: July 16, 2014
Last verified: July 2014
  Purpose

The purpose of study is to test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized veterans at high risk for suicide.


Condition Intervention Phase
Suicidal Ideation
Treatment Engagement
Behavioral: Motivational Interviewing to Address Suicidal Ideation (MI-SI)
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Motivational Interviewing to Prevent Suicide in High Risk Veterans

Resource links provided by NLM:


Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • Severity of Suicidal Ideation [ Time Frame: Six months ] [ Designated as safety issue: No ]
    The severity of suicidal ideation will be measured using the Beck Scale for Suicidal Ideation (SSI) at baseline, 1, 3, and 6 months after discharge.


Secondary Outcome Measures:
  • Treatment Engagement [ Time Frame: Six months ] [ Designated as safety issue: No ]
    Treatment engagement will be measured using the Treatment Services Review-6 (TSR-6) at baseline, 1, 3, and 6 months after discharge.


Estimated Enrollment: 112
Study Start Date: July 2012
Estimated Study Completion Date: July 2016
Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Arm 1
Motivational Interviewing to Address Suicidal Ideation (MI-SI)
Behavioral: Motivational Interviewing to Address Suicidal Ideation (MI-SI)
1 or 2 in-person MI-SI sessions (50 mins.) on an inpatient unit, plus a telephone follow-up MI-SI session (30-50 mins)
No Intervention: Arm 2
Treatment as Usual (TAU)

Detailed Description:

Veterans who receive health care from the VA are at elevated risk for suicide, and the number of veterans at high risk may be growing. Although the months following discharge from psychiatric hospitalization are a period of acute risk for veterans, there is a dearth of empirically supported treatments tailored to psychiatric inpatients and no studies examining treatments for psychiatrically hospitalized veterans. This randomized controlled trial will test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized veterans at high risk for suicide. Participants will be recruited from the Acute Psychiatric Inpatient Unit at the Syracuse VA Medical Center. To meet high-risk criteria, veterans must score over two on the Beck Scale for Suicidal Ideation (SSI), which is prospectively predictive of death by suicide. Participants will complete a screening assessment to confirm eligibility and a baseline assessment of risk factors for suicide. They will be randomized to receive Motivational Interviewing to Address Suicidal Ideation (MI-SI) plus treatment as usual (TAU), or TAU alone. The MI-SI group will receive two sessions of MI-SI during hospitalization and one telephone booster session after discharge. Participants in both conditions will be asked to complete telephone follow-up interviews at 1, 3, and 6 months after discharge. Change in the severity of suicidal ideation will be measured using the SSI.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • veteran status,
  • admitted to psychiatric inpatient unit,
  • age 18 and over,
  • English speaking,
  • able to understand the study and provide informed consent,
  • clinically cleared to participate by unit staff,
  • receive health care from a VA facility in upstate NY,
  • at increased risk for suicide (Beck Scale for Suicidal Ideation [SSI] > 2)

Exclusion Criteria:

  • current psychosis,
  • current mania,
  • dementia,
  • prisoner status,
  • being inaccessible and discharged from the unit less than 48 hours after being identified by study staff
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01544127

Contacts
Contact: Lynn M Knickerbocker (315) 425-4400 ext 56566 lynn.knickerbocker@va.gov
Contact: Andrea Hahn (315) 425-4400 ext 53607 andrea.hahn@va.gov

Locations
United States, New York
Syracuse VA Medical Center, Syracuse, NY Recruiting
Syracuse, New York, United States, 13210
Contact: Mark Polhemus, MD    315-425-2471    Mark.Polhemus@va.gov   
Contact: Lynn M Knickerbocker    (315) 425-4400 ext 56566    lynn.knickerbocker@va.gov   
Principal Investigator: Peter Britton, PhD MS         
Sponsors and Collaborators
Investigators
Principal Investigator: Peter Britton, PhD MS Syracuse VA Medical Center, Syracuse, NY
  More Information

No publications provided

Responsible Party: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT01544127     History of Changes
Other Study ID Numbers: MHBA-20-11S, K2CX00064
Study First Received: February 28, 2012
Last Updated: July 16, 2014
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Veterans
Motivational Interviewing
Inpatients
Suicide, Attempted

Additional relevant MeSH terms:
Suicidal Ideation
Suicide
Behavioral Symptoms
Self-Injurious Behavior

ClinicalTrials.gov processed this record on October 21, 2014